News & Updates
Showing Multidisciplinary articles
Showing

Lower risk of asthma exacerbation with GLP-1 RA vs DPP-4i in patients with DM
A retrospective cohort study conducted in Hong Kong among adults with co-existing asthma and diabetes mellitus (DM) has found a lower risk of asthma exacerbation with glucagon-like peptide-1 receptor agonist (GLP-1 RA) vs dipeptidyl peptidase-4 inhibitor (DPP-4i) treatment.
Lower risk of asthma exacerbation with GLP-1 RA vs DPP-4i in patients with DM
17 Aug 2026
Once-a-week pill for HIV-1 a step closer to reality
People living with HIV (PWH) may soon benefit from a once-weekly treatment regimen instead of the standard daily antiretroviral therapy to manage their condition. Two recent phase III trials, ISLEND-1 and -2, have shown the efficacy of islatravir/lenacapavir (ISL/LEN) vs bictegravir/emtricitabine/tenofovir/alafenamide (B/F/TAF) or standard of care (SOC).
Once-a-week pill for HIV-1 a step closer to reality
15 Aug 2026
Walking with huffing helps clear airway during bronchiectasis exacerbation
Active cycle of breathing technique (ACBT) and walking with huffing demonstrate similar efficacy in improving sputum expectoration and health-related quality of life (HRQOL) in hospitalized adults with exacerbation of bronchiectasis, a study has found.






